JOSHUA HADSELL: Open Payments
NPI 1033736376 · MANDAN, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 25 payments from 8 companies in 2025. Trend: 2023 $618 · 2024 $496 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $167 |
| PFIZER INC. | 3 | $51 |
| Astellas Pharma US Inc | 2 | $48 |
| Amgen Inc. | 2 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
Products named: VRAYLAR, NURTEC ODT, Veozah, ELIQUIS, EVENITY, TRINTELLIX, CAPLYTA, OTEZLA.
Industry payments across ND — which companies pay providers there.
